Literature DB >> 23180348

DeCIDE and PARADIGM: nails in the coffin of induction chemotherapy in head and neck squamous cell carcinoma?

S W Loo, K Geropantas, T W Roques.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 23180348     DOI： 10.1007/s12094-012-0970-4

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN： 1699-048X            Impact factor:   3.405


× No keyword cloud information.
  6 in total

1.  Human papillomavirus and survival of patients with oropharyngeal cancer.

Authors:  K Kian Ang; Jonathan Harris; Richard Wheeler; Randal Weber; David I Rosenthal; Phuc Felix Nguyen-Tân; William H Westra; Christine H Chung; Richard C Jordan; Charles Lu; Harold Kim; Rita Axelrod; C Craig Silverman; Kevin P Redmond; Maura L Gillison
Journal:  N Engl J Med       Date:  2010-06-07       Impact factor: 91.245

Review 2.  Induction chemotherapy in locally advanced squamous cell cancer of the head and neck: evolution of the sequential treatment approach.

Authors:  Marshall R Posner; Robert I Haddad; Lori Wirth; Charles M Norris; Laura A Goguen; Anand Mahadevan; Christopher Sullivan; Roy B Tishler
Journal:  Semin Oncol       Date:  2004-12       Impact factor: 4.929

Review 3.  Revisiting induction chemotherapy for head and neck cancer.

Authors:  Athanassios Argiris; Prathima Jayaram; Diely Pichardo
Journal:  Oncology (Williston Park)       Date:  2005-05       Impact factor: 2.990

4.  Concomitant infusional paclitaxel and fluorouracil, oral hydroxyurea, and hyperfractionated radiation for locally advanced squamous head and neck cancer.

Authors:  M S Kies; D J Haraf; F Rosen; K Stenson; M List; B Brockstein; T Chung; B B Mittal; H Pelzer; L Portugal; A Rademaker; R Weichselbaum; E E Vokes
Journal:  J Clin Oncol       Date:  2001-04-01       Impact factor: 44.544

5.  Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients.

Authors:  Jean-Pierre Pignon; Aurélie le Maître; Emilie Maillard; Jean Bourhis
Journal:  Radiother Oncol       Date:  2009-05-14       Impact factor: 6.280

6.  Correlation between response to cisplatinum-combination chemotherapy and subsequent radiotherapy in previously untreated patients with advanced squamous cell cancers of the head and neck.

Authors:  J F Ensley; J R Jacobs; A Weaver; J Kinzie; J Crissman; J A Kish; G Cummings; M Al-Sarraf
Journal:  Cancer       Date:  1984-09-01       Impact factor: 6.860
  6 in total
  2 in total

1.  Combined EGFR1 and PARP1 Inhibition Enhances the Effect of Radiation in Head and Neck Squamous Cell Carcinoma Models.

Authors:  Barbara A Frederick; Rohit Gupta; Amandla Atilano-Roque; Tin Tin Su; David Raben
Journal:  Radiat Res       Date:  2020-11-10       Impact factor: 2.841

2.  MiR-422a promotes loco-regional recurrence by targeting NT5E/CD73 in head and neck squamous cell carcinoma.

Authors:  Nathalie Bonnin; Emma Armandy; Julien Carras; Sylvain Ferrandon; Priscillia Battiston-Montagne; Marc Aubry; Sébastien Guihard; David Meyronet; Jean-Philippe Foy; Pierre Saintigny; Sonia Ledrappier; Alain Jung; Ruth Rimokh; Claire Rodriguez-Lafrasse; Delphine Poncet
Journal:  Oncotarget       Date:  2016-07-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.